Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Gingival Smile
NCT03812965Phase 2Completed
- Sponsor
- Universidade Ibirapuera
- Start
- Aug 2018
- Primary completion
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of botulinum toxin type A in excessive gingival display (2 arms), sponsored by Universidade Ibirapuera. Primary endpoint: Exposed Gingiva during Smile at 25 weeks. Started Aug 2018; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
excessive gingival display
Beyond the preview
Go deeper on NCT03812965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03812965.